- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 17.68M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $698.77M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $669.61M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $37.29M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $37.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $186.22M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $188.88M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.39B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.35B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $372.83M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $379.77M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.28B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.26B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $912.42M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $876.42M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.66B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.61B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 17.94M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $8.19M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.46M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $27.23M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.95 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.96 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $124.18M |
| Net Income | Q1 2025 · Mar 31, 2024 | $35.23M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $55.53M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $181.56M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $288.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $469.76M |